COMMUNIQUÉS West-GlobeNewswire

Imagin Medical Closing Private Placement

12/04/2018 - 14:30

VANCOUVER, British Columbia, April 12, 2018 (GLOBE NEWSWIRE) -- Imagin Medical (CSE:IME) (OTC PINK:IMEXF) (Frankfurt: DPD2 ) (STUT:DPD2) (the “Company”) announced today that, further to its press release of April 3, [...]

GTX Corp to Present at the Equities Spring 2018 Investor Wealth Conference

12/04/2018 - 14:15

LOS ANGELES, April 12, 2018 (GLOBE NEWSWIRE) -- GTX Corp (OTCBB: GTXO ) , an Internet of Things (IoT) solutions provider in the personal location, wearable and wandering assistive technology business, announced that it [...]

Organovo Presents Data on Modeling Liver Disease Using 3D Bioprinted Human Liver Tissue at The International Liver Congress™

12/04/2018 - 14:05

SAN DIEGO, April 12, 2018 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ: ONVO ) (“Organovo”) today presented data on modeling non-alcoholic fatty liver disease (“NAFLD”) using its 3D bioprinted human liver tissues [...]

Jounce Therapeutics to Present Nonclinical Translational Data at the 2018 American Association for Cancer Research (AACR) Annual Meeting

12/04/2018 - 14:00

CAMBRIDGE, Mass., April 12, 2018 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE ), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers [...]

Impact Health is the First to Implement eTrueNorth’s Technology to Facilitate Quality Control Monitoring

12/04/2018 - 14:00

eTrueNorth’s eQC POCT™ software empowers end-to-end biometric result traceability to the individual point-of-care device and reagent lot number DALLAS, April 12, 2018 (GLOBE NEWSWIRE) -- e TrueNorth, the U.S.-based [...]

International Liver Congress™ 2018 Symposium Highlights Celsion’s ThermoDox® in Treatment of Primary Liver Cancer

12/04/2018 - 14:00

LAWRENCEVILLE, N.J., April 12, 2018 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN), an oncology drug development company, today announced a presentation and discussion of ThermoDox®, its proprietary heat- [...]

Adaptimmune Announces Changes to Board of Directors

12/04/2018 - 14:00

PHILADELPHIA, Pa. and OXFORD, U.K., April 12, 2018 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq: ADAP ), a leader in T-cell therapy to treat cancer, today announced that, in a planned transition, John Furey [...]

Spero Therapeutics Appoints Ian A. Critchley, Ph.D., as Head of Clinical Microbiology

12/04/2018 - 14:00

Building organization to support SPR994 in Phase 3 and beyond, and robust pipeline CAMBRIDGE, Mass., April 12, 2018 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO ), a multi-asset clinical-stage [...]

Catalyst Biosciences Announces Korean Ministry of Food and Drug Safety Approves Addition of Sixth Cohort to the Phase 1/2 Trial of CB 2679d/ISU304 in Individuals with Hemophilia B

12/04/2018 - 14:00

Initiation of Phase 2b Trial on Track for Q3 2018 SOUTH SAN FRANCISCO, Calif., April 12, 2018 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (Nasdaq: CBIO ), a clinical-stage biopharmaceutical company focused on [...]

Establishment Labs Appoints Jeremy Livianu as General Counsel

12/04/2018 - 14:00

NEW YORK, April 12, 2018 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc., a global medical device company focused on breast aesthetics and reconstruction technologies with a strong emphasis on product development [...]

HempAmericana Secures Initial Hemp Material with Potential CBD Oil Sales Yield of $20 Million

12/04/2018 - 14:00

NEW YORK, April 12, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE - HempAmericana, Inc. (OTC:HMPQ) (“HempAmericana” or the “Company”) is excited to announce that the Company has now fully secured sufficient hemp input [...]

Santhera's Shareholders Approve all Board Proposals at Today's Annual General Meeting

12/04/2018 - 13:31

Pratteln, Switzerland, April 12, 2018 - Santhera Pharmaceuticals (SIX: SANN) announces that a large majority of shareholders approved all proposals by the Board of Directors at the Annual General Meeting (AGM) held [...]

Paratek Pharmaceuticals Presenting New Data from Omadacycline Development Program at ECCMID 2018

12/04/2018 - 13:30

- First oral presentation of the results of OASIS-2, the Phase 3 omadacycline oral-only study in ABSSSI - Poster presentations include new microbiology analyses from OASIS-2 BOSTON, April 12, 2018 (GLOBE NEWSWIRE) -- [...]

Cutera Celebrates 20 Years of Best-In-Class Product Innovation

12/04/2018 - 13:30

DALLAS, April 12, 2018 (GLOBE NEWSWIRE) -- ASLMS 2018 ─ At the 2018 American Society for Laser Medicine and Surgery conference, Cutera, Inc. (Nasdaq: CUTR ) (“Cutera” or the “Company”) celebrates 20 years of best-in- [...]

Millennium BlockChain Announces $3M Investment in ImpactPPA’s Decentralized Renewable Energy Platform

12/04/2018 - 13:30

Millennium BlockChain partners with ImpactPPA to disrupt renewable energy financing on the blockchain Las Vegas, NV / Manhattan Beach, CA, April 12, 2018 (GLOBE NEWSWIRE) -- Millennium BlockChain , Inc. (the “Company [...]

Novan Advances Organization and Strengthens Leadership Team

12/04/2018 - 13:05

CEO Role No Longer “Interim” Clinical Operations Role Established Finance Team Positioned for the Future MORRISVILLE, N.C., April 12, 2018 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (NASDAQ: NOVN ) today [...]

Active Biotech's partner NeoTX presents new data at AACR demonstrating that ANYARA enhances the efficacy of checkpoint blockade in preclinical models of cancer

12/04/2018 - 13:01

PRESS RELEASE Lund, April 12, 2018 - Active Biotech (NASDAQ STOCKHOLM: ACTI) today announces that its partner NeoTX Therapeutics Ltd. will present new data for ANYARA (Naptumumab Estafenatox) at the Annual Meeting of [...]

Resverlogix Announces TSX Review Update

12/04/2018 - 13:00

CALGARY, Alberta, April 12, 2018 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix" or the "Company") (TSX: RVX ) announced today it has received a 30-day extension to no later than May 14, 2018 for the TSX’s review [...]

AxoGen, Inc. Announces 2018 Annual Shareholders’ Meeting

12/04/2018 - 13:00

Monday, May 14, 2018 at 4:00 p.m. Eastern Time Hyatt Regency Orlando International Airport ALACHUA, Fla., April 12, 2018 (GLOBE NEWSWIRE) -- AxoGen, Inc. (NASDAQ: AXGN ), a global leader in developing and marketing [...]